MA/p17 matrix protein inhibitors (Quantum Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMA/p17 matrix protein inhibitors (Quantum Pharmaceuticals)
Drug Alias Namep17 matrix protein inhibitors (Quantum Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV p17 matrix protein inhibitors
TargetsHIV p17 matrix protein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuantum Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuantum Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A